A method for the regioselective synthesis of 1-alkyl-1H-indazoles
摘要:
A method for the regioselective synthesis of 3-unsubstituted 1-alkyl-1H-indazoles, starting with 2-halobenzonitriles and N-alkylhydrazines, is described. The two-step reaction pathway proceeds through the intermediacy of 1-alkyl-3-amino-1H-indazoles followed by reductive deamination. (C) 2013 Elsevier Ltd. All rights reserved.
A method for the regioselective synthesis of 1-alkyl-1H-indazoles
摘要:
A method for the regioselective synthesis of 3-unsubstituted 1-alkyl-1H-indazoles, starting with 2-halobenzonitriles and N-alkylhydrazines, is described. The two-step reaction pathway proceeds through the intermediacy of 1-alkyl-3-amino-1H-indazoles followed by reductive deamination. (C) 2013 Elsevier Ltd. All rights reserved.
8-Substituted isoquinoline derivative and the use thereof
申请人:Kaneko Shunsuke
公开号:US20100261701A1
公开(公告)日:2010-10-14
The present invention relates to a compound represented by the following formula (1):
wherein D
1
, A
1
, D
2
, R
1
, D
3
, and R
2
each have the same meaning as defined in the present specification or a salt thereof. The compound represented by the formula (1) or a salt thereof has an IKKβ inhibiting activity and the like and is useful for the prevention and/or treatment of IKKβ-associated diseases or symptoms and the like.
Compounds disclosed herein including compounds of formula I′:
and salts thereof are provided. Pharmaceutical compositions comprising compounds disclosed herein, processes for preparing compounds disclosed herein, intermediates useful for preparing compounds disclosed herein and therapeutic methods for treating an HIV infection using compounds disclosed herein are also provided.
8-SUBSTITUTED ISOQUINOLINE DERIVATIVE AND USE THEREOF
申请人:Asahi Kasei Pharma Corporation
公开号:EP2366699A1
公开(公告)日:2011-09-21
The present invention relates to a compound represented by the following formula (1):
wherein D1, A1, D2, R1, D3, and R2 each have the same meaning as defined in the present specification or a salt thereof. The compound represented by the formula (1) or a salt thereof has an IKKβ inhibiting activity and the like and is useful for the prevention and/or treatment of IKKβ-associated diseases or symptoms and the like.